Hepatitis Forums

Advanced Liver Disease Main Forums => Advanced Liver Disease => Topic started by: Hep Editors on June 26, 2018, 10:24:18 am

Title: Local Therapies With Nexavar Do Not Improve Liver Cancer Survival
Post by: Hep Editors on June 26, 2018, 10:24:18 am
Combining Nexavar (sorafenib) with selective internal radiation therapy (SIRT) or conventional transarterial chemoembolization (TACE) did not improve overall survival for people with liver cancer, but it did lengthen survival for some subgroups of patients, researchers reported at the International Liver Congress this month in Paris.

Over years or decades, chronic hepatitis B or C, heavy alcohol consumption and other causes of liver injury can lead to the development of liver cirrhosis and hepatocellular carcinoma (HCC), the most common type of primary liver cancer, meaning it originates in the liver.